GlassScriptPhysician profile
Maria C Sanchez
NPI 1871836676
$724.73
in general payments reported to CMS, 2019-2025
12 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.75 · 2022: $31.57 · 2023: $150 · 2024: $288 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $212.81 | 2023-2024 | |
| Revance Therapeutics, INC. | $179.07 | 2024-2025 | Daxxify |
| Exeltis, USA INC. | $121.77 | 2024 | Slynd |
| Millicent US INC | $34.49 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $31.57 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.52 | 2024 | Entyvio |
| Kestra Medical Technology Services, INC. | $30.18 | 2025 | Assure Wcd |
| Beigene USA, INC. | $19.74 | 2024 | Tevimbra |
| Corcept Therapeutics | $17.87 | 2024 | Korlym |
| Chiesi USA, INC. | $16.75 | 2021 | |
| Beone Medicines USA, INC. | $15.71 | 2025 | Tevimbra |
| Sage Therapeutics, LLC | $14.25 | 2025 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.